Compounded semaglutide at Forva costs $199 every 4 weeks on a standard 4-week plan (about $216 per calendar month), or as little as $139 every 4 weeks when a 48-week standard plan is paid upfront (about $151 per calendar month). Forva also offers provider-supervised semaglutide microdose plans starting as low as $99 every 4 weeks (about $107 per calendar month) on a 48-week prepaid plan. Prices include the provider visit, medication if prescribed, shipping, and ongoing provider support.
How much does compounded semaglutide cost through Forva?
Forva offers standard compounded semaglutide plans and lower-dose microdose plans, with pricing based on plan type and length.
| Plan | Total paid | Every 4 weeks | About per calendar month |
|---|---|---|---|
| Standard 4-week | $199 | $199 | $216 |
| Standard 12 weeks | $537 | $179 | $194 |
| Standard 24 weeks | $1,014 | $169 | $183 |
| Standard 48 weeks | $1,668 | $139 | $151 |
| Microdose 4-week | $179 | $179 | $194 |
| Microdose 12 weeks | $417 | $139 | $151 |
| Microdose 24 weeks | $714 | $119 | $129 |
| Microdose 48 weeks | $1,188 | $99 | $107 |
The 12-week, 24-week, and 48-week plans are paid upfront. The every-4-weeks figures shown for those plans are the total price divided by the number of 4-week billing cycles in the plan. Forva bills every 4 weeks, which works out to 13 billing cycles a year rather than 12 calendar months.
For standard compounded semaglutide, the lowest effective cost is $139 every 4 weeks on the 48-week prepaid plan. For a provider-supervised semaglutide microdose plan, the lowest effective cost is $99 every 4 weeks on the 48-week prepaid plan.
You can review current options on Forva's weight-loss treatment page.
What is a semaglutide microdose plan?
A semaglutide microdose plan uses a lower-dose approach that may be prescribed by a licensed provider when medically appropriate.
Microdose treatment is not simply a lower-priced version of a standard plan. The appropriate medication, dose, and treatment approach are determined by the licensed provider based on the individual patient's medical information.
At Forva, semaglutide microdose plans range from $179 every 4 weeks on the 4-week plan to an effective $99 every 4 weeks on the 48-week prepaid plan.
As with all Forva GLP-1 treatment, eligibility and prescribing decisions are made by a licensed provider.
What is included in the plan price?
The listed price includes the licensed provider review, compounded semaglutide if prescribed, shipping, and ongoing provider support.
Forva does not add a separate membership fee to its compounded semaglutide plans. This is important when comparing online GLP-1 programs because an advertised medication price does not always represent the full amount a patient will pay.
Forva's compounded GLP-1 plans are self-pay. Insurance is not needed or accepted.
Treatment begins with a short online medical intake. A licensed provider reviews the patient's information and determines whether treatment is medically appropriate. If prescribed, the compounded medication is filled by a licensed U.S. compounding pharmacy and shipped discreetly to the patient's door.
Patients can review the full Forva weight-loss process and treatment options before starting.
Do you pay for medication if the provider does not prescribe it?
No. If the licensed provider determines that GLP-1 treatment is not appropriate, the patient is not charged for medication.
The provider, not Forva, makes the individual eligibility and treatment decision. That review is an important part of provider-supervised telehealth care because a medication that may be appropriate for one person may not be appropriate for another.
Patients who are ready to complete the medical intake can start the Forva weight-loss evaluation.
Is compounded semaglutide the same as Wegovy or Ozempic?
No. Compounded semaglutide should not be described as Wegovy, Ozempic, a generic version of either drug, or an FDA-approved equivalent.
Compounded semaglutide is made by a compounding pharmacy for an individual patient when prescribed. Compounded medications are not FDA-approved, which means the FDA does not review each compounded drug for safety, effectiveness, or quality before it is marketed.
The FDA also distinguishes compounded medications from FDA-approved generic drugs.
Wegovy is an FDA-approved semaglutide product with its own FDA-reviewed prescribing information. Clinical evidence and FDA approvals associated with Wegovy apply to that specific approved product and should not be assumed to apply to a compounded medication.
Forva's compounded medication contains semaglutide as its active ingredient, but it is not the brand-name product and is not an FDA-approved generic.
Why can compounded semaglutide pricing differ from brand-name medication pricing?
Compounded medications and FDA-approved brand-name medications move through different manufacturing, approval, prescribing, and payment systems, so their prices should not be expected to match.
A compounded drug is prepared by a compounding pharmacy for a patient's prescription rather than sold as an FDA-approved brand-name product. The FDA states that compounded drugs can serve an important medical need in appropriate circumstances, but they do not undergo the same premarket approval process as FDA-approved medications.
Forva's prices are self-pay prices for its provider-supervised telehealth program. They include the provider review, medication if prescribed, shipping, and ongoing provider support rather than billing those components separately.
That makes the listed plan price a useful number when comparing the actual out-of-pocket cost of different online programs.
Is compounded semaglutide FDA-approved?
No. Compounded semaglutide is not FDA-approved.
The FDA states that compounded drugs do not undergo agency review for safety, effectiveness, or quality before they are marketed. The agency has also published specific information about unapproved compounded GLP-1 medications and advises patients to obtain prescriptions through licensed healthcare providers and medications from appropriately licensed pharmacies.
This distinction should be clear whenever compounded medication is discussed. A compounded product is not automatically interchangeable with an FDA-approved medication simply because both involve semaglutide.
Eligibility for treatment through Forva is determined by a licensed provider. Results vary, and no particular outcome can be guaranteed.
Can you get compounded semaglutide without insurance?
Yes. Forva's compounded semaglutide plans are self-pay, so patients do not need insurance to use the program.
The published price is what the plan costs rather than an insurance copay estimate. Standard compounded semaglutide costs $199 every 4 weeks on the 4-week plan, with prepaid options that work out to $179, $169, or $139 every 4 weeks.
Provider-supervised semaglutide microdose plans start at $179 every 4 weeks, with prepaid options that work out to $139, $119, or as little as $99 every 4 weeks.
Although Forva does not bill insurance, Forva accepts FSA and HSA cards. Whether a purchase counts as a qualified medical expense is determined by the patient's plan administrator, so patients should check their plan's rules before using those funds.
Forva's compounded GLP-1 service is available in all 50 states, subject to a licensed provider determining that treatment is appropriate.
Patients who want to see how other patients describe their experience can read Forva patient reviews, and common questions about the process are covered in the Forva Help Center.
Which semaglutide plan has the lowest cost every 4 weeks?
The semaglutide microdose 48-week prepaid plan has the lowest effective cost at $99 every 4 weeks, with $1,188 paid upfront.
Among standard compounded semaglutide plans, the 48-week prepaid plan has the lowest effective cost at $139 every 4 weeks, with $1,668 paid upfront.
The right plan is not necessarily the longest or lowest-priced option for every patient. Plan length is a financial choice, while whether semaglutide is appropriate, whether a microdose approach is appropriate, and what treatment a patient should receive if prescribed are medical decisions made by a licensed provider.
Forva's pricing is designed to make the full compounded-plan cost visible before a patient begins the provider-supervised process, without adding a separate membership fee later.
This article is for general information and is not medical advice. Eligibility and treatment decisions are made by a licensed provider.